Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Low vs high kappa-angle compensation during SMILE with VisuMax 800

Official title: Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Clinical Trial

Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07512102 · Data updated 2026-11-12

This trial tests whether using a low (50%) or high (100%) kappa-angle compensation during SMILE surgery with the VisuMax 800 produces better postoperative vision for adults with myopia and large kappa offsets.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment100 (estimated)
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedApril 8, 2026
Main results expectedMay 30, 2027
Study endsMay 30, 2027
Registry record updatedJuly 7, 2026
Trial IDNCT07512102 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–40 with stable myopia or myopic astigmatism and a kappa offset of at least 0.20 mm, suitable corneal anatomy, and normal preoperative vision.

Probably not a fit

Patients without significant kappa offset or unsuitable corneal characteristics may not benefit from altered compensation strategies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center, randomized study, adults aged 18–40 with stable myopia or myopic astigmatism and a sizable kappa offset will be assigned to one of two intraoperative visions for centering the SMILE treatment. The VisuMax 800 laser’s machine-vision alignment allows the surgeon to compensate for the visual axis offset during the procedure. The primary question is whether low kappa-angle compensation reduces higher-order aberrations compared with high compensation, with secondary outcomes including simple visual acuity, refractive accuracy, contrast sensitivity, and subjective visual quality. The trial aims to clarify the optimal intraoperative centering strategy for patients with larger kappa offsets undergoing SMILE. Outcome measures include postoperative visual quality and stability of refractive results.

Why it matters

Potential benefit: If successful, the study could define an optimal compensation strategy to improve postoperative visual quality for patients with large kappa offsets undergoing SMILE.

How similar studies have gone: Prospective randomized work in refractive surgery has explored kappa compensation in other modalities, but SMILE-specific randomized data in this area are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age range: 18 - 40 years old. Patients with stable refractive status for \>= 1 year, having myopia or myopic astigmatism, with refractive power within the range of SMILE procedure.
2. Normal corneal morphology and corneal thickness meeting the surgical requirements.
3. Best corrected visual acuity (CDVA) before surgery \>= 1.0.
4. The kappa angle-related offset coordinates (x, y) obtained before surgery, with the absolute value of either \|x\| or \|yl\| of any eye \>= 0.20mm.
5. Voluntary to undergo SMILE surgery on the VISUMAX800 platform, understanding the random grouping scheme and signing the informed consent form.

Exclusion Criteria:

1. History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery.
2. Severe systemic diseases that may affect ocular healing or surgical safety.
3. Females who are pregnant or lactating.
4. Inability to cooperate as required to complete the procedure or follow-up visits.

Where it's running

  • Zhongshan Ophthalmic Center
    Guangzhou, Guangdong, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.